Incidence and prognosis of cancer following heart transplantation using RATG induction therapy

Transplant International

Volumn 18, Issue 11, 2005, Pages 1280-1285

  El Hamamsy, Ismaïl ^a   Stevens, Louis Mathieu ^a   Carrier, Michel ^a   Pelletier, Guy ^a   White, Michel ^a   Tremblay, Francine ^b   Perrault, Louis P ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Cancer; Heart transplantation; Induction therapy; Thymoglobuline

Indexed keywords

AZATHIOPRINE; DIPHENHYDRAMINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARACETAMOL; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; LUNG TUMOR; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROSTATE TUMOR; SKIN TUMOR; UROGENITAL TRACT TUMOR;

ADOLESCENT; ADULT; ANTILYMPHOCYTE SERUM; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 28444449100     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2005.00203.x     Document Type: Article

References (17)

1. Cole WH. The increase in immunossuppression and its role in the development of malignant lesions. J Surg Oncol 1985; 30: 139.
2. Olivari MT, Diekmann RA, Kubo SH, Braunlin E, Jamieson SW, Ring WS. Low incidence of neoplasia in heart and heart-lung transplant recipients receiving triple-drug immunosuppression. J Heart Transplant 1990; 9: 618.
3. Couetil JP, McGoldrick JP, Wallwork J, English TA. Malignant tumors after heart transplantation. J Heart Transplant 1990; 9: 622.
4. MacLeod AM, Catto GR. Cancer after transplantation. Br Med J 1988; 297: 4.
5. Penn I. Cancers complicating organ transplantation. N Engl J Med 1990; 323: 1767.
6. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al. Increased incidence of lymphoproliferative disorder after immunossupression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 1990; 323: 1723.
7. Carrier M, White M, Perrault LP, et al. A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation. J Heart Lung Transplant 1999; 18: 1218.
8. Zuckermann AO, Grimm M, Czerny M, et al. Improved long-term results with thymoglobuline induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulines. Transplantation 2000; 69: 1890.
9. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Tranplant 1990; 9: 587.
10. Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant. 2004; 4: 222.
11. Mihalov ML, Gattuso P, Abraham K, Holmes EW, Reddy V. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. Clin Transplant 1996; 10: 248.
12. Buell JF, Trofe J, Hanaway MJ, et al. Transmission of donor cancer into cardiothoracic transplant recipients. Surgery 2001; 130: 660.
13. Goldstein DJ, Williams DL, Oz MC, Weinberg AD, Rose EA, Michler RE. De novo solid malignancies after cardiac transplantation. Ann Thorac Surg 1995; 60: 1783.
14. Pham SM, Kormos RL, Landreneau RJ, et al. Solid tumors after heart transplantation: lethality of lung cancer. Ann Thorac Surg 1995; 60: 1623.
15. Wilkinson AH, Smith JL, Hunsicker LG, et al. Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation 1989; 47: 293.
16. Tremblay F, Fernandes M, Habbab F, deB Edwardes MD, Loertscher R, Meterissian S. Malignancy after renal transplantation: incidence and role of type of immunosuppression. Ann Surg Oncol 2002; 9: 785.
17. Hemmens VJ, Moore DE. Photochemical sensitization by azathioprine and its metabolites-II. Azathioprine and nitroimidazole metabolites. Photochem Photobiol 1986; 43: 257.